This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novo Nordisk A/s. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Emiliano Clo: Innovator in Protein Conjugates
Introduction
Emiliano Clo is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of protein conjugates. His innovative work has led to advancements that could have a profound impact on various applications in medicine and research.
Latest Patents
Emiliano Clo holds 1 patent related to protein conjugates. His invention focuses on conjugates of more than two proteins or polypeptides. The compounds he developed include a trivalent linker moiety that enables efficient production of desired products. This innovation is poised to enhance the effectiveness of protein-based therapies.
Career Highlights
Emiliano Clo is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to work at the forefront of biopharmaceutical innovation. His expertise in protein conjugates is instrumental in the company's ongoing research and development efforts.
Collaborations
Emiliano has collaborated with several talented individuals in his field, including Henrik Sune Ramirez-Andersen and Nils Langeland Johansen. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of scientific knowledge.
Conclusion
Emiliano Clo's contributions to the field of protein conjugates exemplify the spirit of innovation in biotechnology. His work at Novo Nordisk and his patent on protein conjugates highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
